GlaxoSmithKline Status
Woodford Investment Management sold the shares of the company's (LON: GSK) common stock, raising an undisclosed amount on May 12, 2017.
In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
Employees
113.2 K
RevenueTTM 1Q2019
$41 B
Net IncomeTTM 1Q2019
$5.1 B
General Information
-
Website
-
Business Status
Profitable
-
Ownership Status
Publicly Held
-
Financing Status
Corporation
GlaxoSmithKline News and Updates
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal: Report - The Jakarta Post
Jakarta Post | July 5, 2020
Is Dynavax Technologies Stock a Buy?
The Motley Fool | July 5, 2020
Glaxo, Sanofi discussing $620 million U.K. vaccine deal
Beaumont Enterprise | July 5, 2020
Post COVID 19 Pandemic Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Research Report 2020 Top Players Include, Emotional Brain BV, GlaxoSmithKline Plc, Palatin Technologies Inc, Pivot Pharmaceuticals Inc, Strategic Science & Technologies LLC
Bandera County Courier | July 5, 2020
GlaxoSmithKline's Feed
GlaxoSmithKline's Verticals
GlaxoSmithKline Primary Industry Sector / Group / Code
GlaxoSmithKline's Trends
GlaxoSmithKline Metrics
Growth Rate
SimilarWeb Unique Visitors
Twitter Followers
Headquarters
-
HQ Address Line 1980 Great West Road
-
HQ CityBrentford
-
HQ State/ProvinceEngland
-
HQ Post CodeTW8 9GS
-
HQ CountryUnited Kingdom
GlaxoSmithKline's Keywords
Add a review